[ALTERATION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY A CYTOSTATIC OF THE METHYLHYDRAZINE GROUP].
D000818:Animals; D000917:Antibody Formation; D000970:Antineoplastic Agents; D054697:Cytostatic Agents; D004679:Encephalomyelitis; D004681:Encephalomyelitis, Autoimmune, Experimental; D006834:Hydrazines; D006967:Hypersensitivity; D007970:Leukopenia; D008214:Lymphocytes; D009002:Monomethylhydrazine; D011817:Rabbits; D012106:Research
D000970:Antineoplastic Agents; D054697:Cytostatic Agents; D006834:Hydrazines; D009002:Monomethylhydrazine
ANTIBODY FORMATION; ANTINEOPLASTIC AGENTS; ENCEPHALOMYELITIS; EXPERIMENTAL LAB STUDY; HYDRAZINES; HYPERSENSITIVITY; LEUKOPENIA; LYMPHOCYTES; RABBITS
BEEINFLUSSUNG DER EXPERIMENTELLEN ALLERGISCHEN ENCEPHALOMYELITIS DURCH EIN CYTOSTATICUM DER METHYLHYDRAZINREIHE.